Literature DB >> 16621967

Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration.

Benoit Favier1, Antoine Alam, Pauline Barron, Jacques Bonnin, Patricia Laboudie, Pierre Fons, Marie Mandron, Jean-Pascal Herault, Gera Neufeld, Pierre Savi, Jean-Marc Herbert, Françoise Bono.   

Abstract

Neuropilin 2 (NRP2) is a receptor for the vascular endothelial growth factor (VEGF) and the semaphorin (SEMA) families, 2 unrelated ligand families involved in angiogenesis and neuronal guidance. NRP2 specifically binds VEGF-A and VEGF-C, although the biological relevance of these interactions in human endothelial cells is poorly understood. In this study, we show that both VEGF-A and VEGF-C induce the interaction of NRP2 with VEGFR-2. This interaction correlated with an enhancement of the VEGFR-2 phosphorylation threshold. Overexpression of NRP2 in primary human endothelial cells promoted cell survival induced by VEGF-A and VEGF-C. In contrast, SEMA3F, another ligand for NRP2, was able to inhibit human endothelial cell survival and migration induced by VEGF-A and VEGF-C. Moreover, a siRNA targeting specifically NRP2 was a potent inhibitor of human endothelial cell migration induced by VEGF-A and VEGF-C. Thus, our data indicate that NRP2 acts as a coreceptor that enhances human endothelial cell biological responses induced by VEGF-A and VEGF-C.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621967     DOI: 10.1182/blood-2005-11-4447

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  119 in total

Review 1.  Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer.

Authors:  Atsuko Sakurai; Colleen L Doçi; Colleen Doci; J Silvio Gutkind
Journal:  Cell Res       Date:  2011-12-13       Impact factor: 25.617

Review 2.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 3.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

4.  Down-regulation of DLC1 in endothelial cells compromises the angiogenesis process.

Authors:  Yi-Ping Shih; Sarah Y Yuan; Su Hao Lo
Journal:  Cancer Lett       Date:  2017-04-10       Impact factor: 8.679

Review 5.  Gene and protein therapies utilizing VEGF for ALS.

Authors:  Orion P Keifer; Deirdre M O'Connor; Nicholas M Boulis
Journal:  Pharmacol Ther       Date:  2013-10-29       Impact factor: 12.310

6.  Paxillin controls endothelial cell migration and tumor angiogenesis by altering neuropilin 2 expression.

Authors:  Alexandra E German; Tadanori Mammoto; Elisabeth Jiang; Donald E Ingber; Akiko Mammoto
Journal:  J Cell Sci       Date:  2014-02-12       Impact factor: 5.285

7.  Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency.

Authors:  Patrick Mucka; Nicholas Levonyak; Elena Geretti; Bernadette M M Zwaans; Xiaoran Li; Irit Adini; Michael Klagsbrun; Rosalyn M Adam; Diane R Bielenberg
Journal:  Am J Pathol       Date:  2016-10-14       Impact factor: 4.307

8.  Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding.

Authors:  Brent A Appleton; Ping Wu; Janice Maloney; JianPing Yin; Wei-Ching Liang; Scott Stawicki; Kyle Mortara; Krista K Bowman; J Michael Elliott; William Desmarais; J Fernando Bazan; Anil Bagri; Marc Tessier-Lavigne; Alexander W Koch; Yan Wu; Ryan J Watts; Christian Wiesmann
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

Review 9.  Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion.

Authors:  Martine Perrot-Applanat; Melanie Di Benedetto
Journal:  Cell Adh Migr       Date:  2012-11-01       Impact factor: 3.405

10.  Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients.

Authors:  Ricardo Saban; Marcia R Saban; Julie Maier; Ben Fowler; Mark Tengowski; Carole A Davis; Xue-Ru Wu; Daniel J Culkin; Paul Hauser; Joseph Backer; Robert E Hurst
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.